June 2022 • PharmaTimes Magazine • 9

// CONDITIONS //


Superdrug launch comprehensive perimenopause screen service

Image

Superdrug has announced the launch of the UK’s first perimenopause health screen service on the high street. It will support those experiencing symptoms such as hot flushes, night sweats and erratic menstrual flow, which are often not considered to be serious.

The service is an in-clinic blood test conducted by Superdrug nurses, which looks at key hormonal levels.

Caris Newson, head of healthcare services at Superdrug, commented: “Our perimenopause health screen service makes it as convenient as possible for people to get professional advice, consider strategies to manage their symptoms or pursue treatment options which could significantly improve their quality of life.”

The test will also examine reproductive hormones, minerals, cardiovascular health and thyroid profile. Reproductive hormones can affect health by increasing risk of cardiovascular disease and osteoporosis – a heart condition weakening bones making them more likely to break.

In addition, calcium, magnesium and vitamin D levels are also checked by the team of nurses, as these can worsen menopausal-related symptoms.

Perimenopause is the stage approaching menopause during which the hormones begin changing. Approximately 13 million in the UK are either peri- or post-menopausal, with perimenopause symptoms sometimes lasting as long as 15 years.


80% of children may develop allergies if parents have them

Image

New data from London Medical Laboratory’s allergy tests indicate 40% of UK children have allergies and up to 80% of children with two allergic parents may develop them at some point.

The study also suggests that one in ten UK children may suffer from potentially severe food allergies. It says that parents must learn to spot early symptoms and keep their schools informed.

There are numerous symptoms that parents should be mindful of, as it may indicate that their child has developed an allergy. These include a runny or blocked nose, sneezing, watering eyes, an itching or tingling in the mouth, hives or a red rash.

The leading testing expert, Dr Quinton Fivelman at London Medical Laboratory, commented: “Looking at the results of our allergy tests, one in ten children may have a specific food allergy – notably higher than Allergy UK’s one in twelve figure. Most significantly, our data also shows a potential link between children with allergies and those children’s parents also having an allergy.”

The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well-known potential food allergens, such as nuts, shellfish and eggs. It also includes common foods less likely to trigger allergies but still known allergens, such as strawberries, mustard, carrots and avocado.


HOT & NOT

Eli Lilly’s Verzenios (abemaciclib) has received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA), in combination with endocrine therapy for the adjuvant treatment of patients with HR+, HER2-, high risk node-positive early breast cancer.
  
The approval was based on results from the phase 3 monarchE trial which involved a huge international effort of 5,637 patients. Treatment with Verzenios in combination with edocrine therapy reduced risk of breast cancer recurrence by 32%.


AstraZeneca has announced that Forxiga (dapagliflozin) has been accepted for restricted use within NHS Scotland by the Scottish Medicines Consortium (SMC).

The therapy is for the treatment of adults with chronic kidney disease (CKD) and will give eligible patients in Scotland access to the first new additional treatment option indicated for the condition in nearly 20 years.

AstraZeneca estimates that as many as 53,000 adults living with CKD in Scotland could be entitled to this treatment under the recommendation.


The National Institute for Health and Care Excellence (NICE) has advised that exercise should be a 'core treatment' for arthritis, in new draft guidelines for the NHS. The institute has shared that aspirin can be effective but did not advise the routine use of paracetamol or opioid drugs to manage pain.

The new NHS guidance from NICE recommends aerobic exercise including walking and also recommends strength training, to reduce symptoms and increase quality of life.


Researchers from Queen Mary University of London and Barts Health NHS Trust are trialling an investigational medication for high blood pressure.

It marks the first time that scientists will be trialling an injection-based approach with a long-acting medicine to treat hypertension.
If successful, the new treatment regime could revolutionise how blood pressure is treated for adults with the condition.


Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are missing out.

New data by PwC for the Association of the British Pharmaceutical Industry (ABPI) highlights the potential benefits of increased investment in clinically and cost-effective new medicines to patients, society and the economy.

The research reveals how the improved use of 13 medicines across four treatment areas – stroke prevention, kidney disease, asthma and type 2 diabetes – can transform patient care.


The Global Antibiotic Research and Development Partnership has released a second wave of findings from a large study which focuses on new-born babies with clinically diagnosed sepsis – a life-threatening bloodstream infection.

The results have revealed the significant impact of antibiotic resistance on neonatal sepsis – a major cause of death that affects up to three million babies a year. The study looked at the outcomes of more than 3,200 newborns with neonatal sepsis and revealed that an increasing number of babies die due to resistant infections.